Question 1

Am I eligible for this trial based on my current treatment and health status?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer clinical trial (NCT00126230). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of the docetaxel-samarium treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer clinical trial (NCT00126230). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options I have?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer clinical trial (NCT00126230). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer clinical trial (NCT00126230). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect in terms of monitoring and tests during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer clinical trial (NCT00126230). Contact the study team or your healthcare provider for specific answers.

Question 6

How will participating in this trial affect my overall treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of Docetaxel-samarium in Patients With Hormone-refractory Advanced Prostate Cancer clinical trial (NCT00126230). Contact the study team or your healthcare provider for specific answers.

What this study is about